Contact Us

    Your Name (required)

    Your Email (required)

    Your Phone (required)


    Interested In... (required)

    Your Message

    Woodfield Distribution, LLC Acquires Generic Pharmaceutical Company Florida Pharmaceutical Products, Inc.

    Woodfield Distribution, LLC Acquires Florida Pharmaceutical Products, Inc.

    Boca Raton, FL (August 13, 2018) – Florida Pharmaceutical Products, Inc., a company involved in the development of Generic Pharmaceuticals, was acquired by Woodfield Distribution, LLC, a Boca Raton, FL based Logistics Services Provider. Terms were not disclosed.

    Florida Pharmaceutical Products, Inc., focuses on improving patient outcomes with generic medications spanning a broad therapeutic range.  Investments fund research to identify new treatments and guiding strong product candidates through the development lifecycle.

    The company was created in 1999 by the late Laurence Runsdorf who ran operations until his death in May, 2018.  Runsdorf, a leading figure in the development of the modern generic pharmaceutical industry, founded Breckenridge Pharmaceutical, Inc., and served as President until his retirement in 2014.

    Concurrent with the acquisition, Woodfield Distribution, LLC President Adam Runsdorf named Larry Lapila as President of Florida Pharmaceutical Products, Inc.  Lapila is a 35-year veteran in the generics industry with expertise in sales, marketing, business development, portfolio management and other executive functions including serving as President of a major generics company for the past 17 years.

    “I am pleased Larry is joining us to continue the work my father began at Florida Pharmaceutical Products, Inc.,” stated Runsdorf, the son of the late Laurence Runsdorf.  “The company is uniquely positioned with a robust pipeline and many opportunities that will result in better patient health.

    “This is a great opportunity for me to build on what Florida Pharmaceutical Products, Inc., has achieved and invested in up to this point and I am excited to take on this new challenge and continue Larry Runsdorf’s legacy,” said Lapila.

    For further information contact WDSrx at or (561) 998-3885.

    Larry Lapila, President of Florida Pharmaceutical Products, Inc.

    Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at or (561) 998-3885 x316.